Hatterer J A, Kocsis J H, Stokes P E
New York State Psychiatric Institute, New York.
Psychiatry Res. 1988 Dec;26(3):249-57. doi: 10.1016/0165-1781(88)90118-7.
To determine the clinical significance of thyroid function abnormalities in patients maintained on lithium, the authors evaluated the relationships of thyroid function tests to clinical response to lithium and side effects from lithium in 20 outpatients meeting DSM-III criteria for major affective disorder. No significant relationships were found between baseline thyroid function tests and clinical response. Thyroxine (T4) and triiodothyronine uptake ratio (T3UR) within the normal range were found to be associated with complaints of lethargy and cognitive impairment. Thirteen subjects were followed prospectively for 6 months with monthly evaluations of affective state, side effects, and occurrence of relapse. Thyroid function tests were repeated at the final visit. Final and mean T3 levels within the normal range were found to be significantly lower in patients who relapsed, and mean T3 level was inversely correlated with affective state as measured by mean scores on the Hamilton Rating Scale for Depression and the Young Mania Rating Scale.
为了确定服用锂盐维持治疗的患者甲状腺功能异常的临床意义,作者评估了20名符合DSM-III标准的重度情感障碍门诊患者的甲状腺功能测试结果与锂盐临床反应及副作用之间的关系。未发现基线甲状腺功能测试与临床反应之间存在显著关系。发现甲状腺素(T4)和三碘甲状腺原氨酸摄取率(T3UR)在正常范围内与嗜睡和认知障碍主诉相关。对13名受试者进行了为期6个月的前瞻性随访,每月评估情感状态、副作用和复发情况。在最后一次随访时重复进行甲状腺功能测试。发现复发患者的最终和平均T3水平在正常范围内显著较低,并且平均T3水平与汉密尔顿抑郁量表和杨氏躁狂量表的平均得分所衡量的情感状态呈负相关。